SCHEMBL22894532

SCHEMBL22894532

CCC(C)C(=O)c1cc(C)c(O)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.39
ESR1 P03372 3/20 0.39
MAPT P10636 3/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
CHRNA1 P02708 1/20 0.36
CHRNG P07510 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRND Q07001 1/20 0.36
FBP1 P09467 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20607115 0.84 TTR (0.41) TTRESR1MEN1KMT2ASLC6A2
SCHEMBL17732583 0.83 TTR (0.44) TTRESR1LMNASLC6A2SLC6A4
SCHEMBL10000323 0.75 KDM4E (0.45) ESR1MAPTMEN1LMNATP53
SCHEMBL9407170 0.75 HSP90AA1 (0.55) LMNASLC6A2SLC6A4SLC6A3CHRNA1
SCHEMBL28743655 0.74 CHRNA1 (0.35) MAPTLMNASLC6A2SLC6A4SLC6A3
SCHEMBL17300665 0.73 TTR (0.41) TTRESR1LMNASLC6A2SLC6A4
SCHEMBL20607132 0.73 TTR (0.50) TTRESR1ALDH1A1SMN1; SMN2HPGD
SCHEMBL3595464 0.73 ESR1 (0.59) ESR1MAPTLMNAPKMSMN1; SMN2
SCHEMBL983707 0.73 TTR (0.72) TTRMAPTLMNATP53MAPK1
SCHEMBL2716447 0.73 TTR (0.48) TTRESR1LMNAPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423440-B1 5-METHYL-6-PHENYL-4,5-DIHYDRO-2H-PYRIDAZIN-3-ONE DERIVATIVE FOR THE TREATMENT OF BRAIN TUMORS OTSUKA PHARMA CO LTD (JP) 2021-01-06 EP disclosed